Kite Pharma, Inc. Insider Trading for December 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. for December 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Option Exercise | M | 1.35 | 10,000 | 13,500 | 335,394 | |
| Dec 29 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Sell | S | 61.99 | 2,710 | 167,993 | 94,007 | 96.7 K to 94 K (-2.80 %) |
| Dec 29 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Sell | S | 61.40 | 7,290 | 447,606 | 96,717 | 104 K to 96.7 K (-7.01 %) |
| Dec 29 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Buy | M | 1.35 | 10,000 | 13,500 | 104,007 | 94 K to 104 K (+10.64 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Option Exercise | A | 63.87 | 160,000 | 10,219,200 | 160,000 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Grant | A | 0.00 | 44,000 | 0 | 54,000 | 10 K to 54 K (+440.00 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Option Exercise | A | 63.87 | 8,800 | 562,056 | 8,800 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Grant | A | 0.00 | 5,800 | 0 | 7,688 | 1.9 K to 7.7 K (+307.20 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | A | 63.87 | 8,800 | 562,056 | 8,800 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Grant | A | 0.00 | 5,800 | 0 | 8,741 | 2.9 K to 8.7 K (+197.21 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | A | 63.87 | 24,800 | 1,583,976 | 24,800 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Grant | A | 0.00 | 6,900 | 0 | 9,098 | 2.2 K to 9.1 K (+313.92 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | A | 63.87 | 26,400 | 1,686,168 | 26,400 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Grant | A | 0.00 | 7,400 | 0 | 13,742 | 6.3 K to 13.7 K (+116.68 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Option Exercise | A | 63.87 | 33,000 | 2,107,710 | 33,000 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Grant | A | 0.00 | 9,200 | 0 | 9,200 | 0 to 9.2 K |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Med ... | Option Exercise | A | 63.87 | 66,100 | 4,221,807 | 66,100 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Med ... | Grant | A | 0.00 | 18,500 | 0 | 25,404 | 6.9 K to 25.4 K (+267.96 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Option Exercise | A | 63.87 | 66,100 | 4,221,807 | 66,100 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Grant | A | 0.00 | 18,500 | 0 | 94,007 | 75.5 K to 94 K (+24.50 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Option Exercise | A | 63.87 | 100,700 | 6,431,709 | 100,700 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Grant | A | 0.00 | 28,200 | 0 | 28,200 | 0 to 28.2 K |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | M | 6.89 | 9,000 | 62,010 | 103,000 | |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 65.27 | 491 | 32,048 | 6,342 | 6.8 K to 6.3 K (-7.19 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 64.58 | 3,488 | 225,255 | 6,833 | 10.3 K to 6.8 K (-33.80 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 63.59 | 2,285 | 145,303 | 10,321 | 12.6 K to 10.3 K (-18.13 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 62.64 | 2,736 | 171,383 | 12,606 | 15.3 K to 12.6 K (-17.83 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Buy | M | 6.89 | 9,000 | 62,010 | 15,342 | 6.3 K to 15.3 K (+141.91 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 17.00 | 645 | 10,965 | 33,233 | |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 5,500 | 3,850 | 96,625 | |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 64.97 | 1,145 | 74,391 | 2,198 | 3.3 K to 2.2 K (-34.25 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 64.27 | 2,400 | 154,248 | 3,343 | 5.7 K to 3.3 K (-41.79 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 62.76 | 2,600 | 163,176 | 5,743 | 8.3 K to 5.7 K (-31.16 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 17.00 | 645 | 10,965 | 8,343 | 7.7 K to 8.3 K (+8.38 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 5,500 | 3,850 | 7,698 | 2.2 K to 7.7 K (+250.23 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 123,464 | |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 65.38 | 432 | 28,244 | 2,941 | 3.4 K to 2.9 K (-12.81 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 64.64 | 3,352 | 216,673 | 3,373 | 6.7 K to 3.4 K (-49.84 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 63.73 | 2,410 | 153,589 | 6,725 | 9.1 K to 6.7 K (-26.38 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 62.70 | 3,373 | 211,487 | 9,135 | 12.5 K to 9.1 K (-26.97 %) |
| Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 12,508 | 2.9 K to 12.5 K (+325.30 %) |
| Dec 03 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Option Exercise | M | 0.38 | 9,000 | 3,420 | 78,000 | |
| Dec 03 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 82.42 | 90 | 7,418 | 1,888 | 2 K to 1.9 K (-4.55 %) |
| Dec 03 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 80.59 | 100 | 8,059 | 1,978 | 2.1 K to 2 K (-4.81 %) |
| Dec 03 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 78.53 | 254 | 19,947 | 2,078 | 2.3 K to 2.1 K (-10.89 %) |
| Dec 03 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 77.50 | 1,215 | 94,163 | 2,332 | 3.5 K to 2.3 K (-34.25 %) |
| Dec 03 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 76.57 | 3,664 | 280,552 | 3,547 | 7.2 K to 3.5 K (-50.81 %) |
| Dec 03 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 75.48 | 2,772 | 209,231 | 7,211 | 10 K to 7.2 K (-27.77 %) |
| Dec 03 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 74.53 | 905 | 67,450 | 9,983 | 10.9 K to 10 K (-8.31 %) |
| Dec 03 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Buy | M | 0.38 | 9,000 | 3,420 | 10,888 | 1.9 K to 10.9 K (+476.69 %) |